Please note the following document from the ECDC on Ebola and SoHO: “Risk of Bundibugyo virus transmission through substances of human origin in the European Union/European Economic Area (EU/EEA)”.

The Federal Office for Safety in Health Care (BASG) has been informed by the Italian authorities that in Italy, in addition to the provinces already announced, the ID WNV NAT test for donations of blood and blood components has been introduced in Florence.

The donor/the donor gametes have been permanently blocked.

In accordance with Article 152 of Regulation (EU) 2019/6, all marketing authorisations for veterinary medicinal products (VMPs) granted under Directive 2001/82/EC, as amended, must be updated to align their product information with QRD template version 9.These updates must be completed at the latest by 29 January 2027, after which all products placed on the market must have product information compliant with QRD v9.

The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease Prevention and Control) that human WNV infections have been recorded in North Macedonia, in Vardar.

Precautionary batch recall, as there may be glass splinters in the bottles

Recall due to possible contamination with glass splinters

Recall due to reduced release of active pharmaceutical ingredient

Many of the offered "peptides" are classified as medicinal products without marketing authorisation by the Austrian Federal Office for Safety in Health Care (BASG) depending on their composition, concentration, effects and scientific data.

The BASG warns against illegal medicinal products (illegal medicinal product by presentation) marketed under the misleading name "GLP-1" because of their claims.